Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
Clinical trial NCT04944524 · UNKNOWN
Trial details
- NCT number
- NCT04944524
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.